SPONSOR
Incyte Corporation
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 3, Phase 2
Conditions studied: Myeloproliferative NeoplasmsNonSegmental VitiligocGVHDHidradenitis Suppurativa (HS)Chronic Graft-versus-host-disease
Incyte Corporation is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Myeloproliferative Neoplasms, NonSegmental Vitiligo, cGVHD, Hidradenitis Suppurativa (HS).
The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Incyte Corporation
How many clinical trials has Incyte Corporation sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Incyte Corporation, of which 6 are actively recruiting participants. These trials cover conditions including Myeloproliferative Neoplasms, NonSegmental Vitiligo, cGVHD. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Incyte Corporation research focus on?
Incyte Corporation clinical trials span Myeloproliferative Neoplasms, NonSegmental Vitiligo, cGVHD, Hidradenitis Suppurativa (HS), Chronic Graft-versus-host-disease. The research pipeline includes Phase 1, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Incyte Corporation clinical trial?
To participate in a Incyte Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Incyte Corporation trials with current recruitment status updated daily.
Clinical Trials by Incyte Corporation
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
NCT05919511
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
cGVHD
NCT06804811 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
NonSegmental Vitiligo
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Chronic Graft-versus-host-disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology